10. Thorsteinsson L, Blöndal H, Jensson O, Gudmundsson
G. Distribution of cystalin C amyloid deposits in the leelan–
die patients with hereditary cystalin C amyloidangiopathy.
In
Amyloid and Amyloidosis (Isobe T, Araki S, Uchino F, Kito
S, Tsubura E, Eds.) New York: Plenum Publisbing Corpora–
tion, 1988, pp 585-590.
11. Benedikz E, Blöndal H, Gudmundsson G. Skin deposits
in hereditary cystalin C amyloidosis. Virchows Archiv A
Pathol Anat 1990; 417: 325-331.
12. Grubb A, Jensson O, Gudmundsson G, Amason A,
Löfberg H, MalmJ. Abnormal metabolismof y-trace alkaline
microprotein. The basic defect in hereditary cerebral
hernorrhage with amyloidosis. N Engl J Med 1984; 311:
1547-1549.
13. Abrahamson M, Olafsson I, Palsdottir A, Ulvsbäck M,
Lundwall
Å,
Jensson O, Grubb A. Structure and expression
ofthe human cystalin C gene. Biochem J 1990; 268: 287-294.
14. Abrahamson M, Islam MQ, Szpirer J, Szpirer C, Levan
G. The human cystalin C gene (CST3), mutated in hereditary
cystalin C amyloid angiopathy, is locatedon chromosome 20.
Hum Genet 1989; 82: 223-226.
15. Rao VVNG, Schnittger S, Abrahamson M, Hansmann
I.
Cystalin-C and other farnily 2 cystalins map to two different
loci on chromosome 20. Am J Hum Genet Suppl 1991; 49:
387. (Abstract)
16. Palsdottir A, Abrahamson M, Thorsteinsson L, Amason
A, Olafsson I, Grubb A, Jensson O. Mutation in cystalin C
gene eauses hereditary brain haemorrhage. Lancet 1988;
ii:
603-604.
17. Levy E, Lopez-Otin C, Ghiso J, Geltner D, Frangione B.
Stroke in leelandie patients with hereditary amyloid
angiopathy is related to a mutation in the cystalin C gene, an
inhibitor of cysteine proteases. J Exp Med 1989; 169: 1771-
1778.
22
18. Abrahamson M, Jonsdottir S, Olafsson I, Jensson O,
Grubb A. Hereditary cystatiD C amyloid angiopathy:
ldentification of the disease-causing mutation and specific
diagnosis by polymerase chain reaction based analysis. Hum
Genet 1992; 89: 377-380.
19. Abrahamson M, Grubb A, Olafsson I, Lundwall
Å.
Molecular cloning and sequence analysis of cDNA coding
for the precursor of the human cysteine proteinase inhibitor
cystalin C. FEBS Lett 1987; 216: 229-233.
20. Jonsdottir S, Palsdottir A, Abrahamson M, Grubb A,
Jensson O. Molecular biology of hereditary cystatin C
amyloid angiopathy in Iceland. In Amyloid and Amyloidosis
(Natvig
JB,
F~rre
0,
Husby G, Husebell A, Skogen B,
Sletten K,Westermark P, Eds.) Dordrecht: Kluwer Academic
Publishers), 1991, pp 361-364.
21. Jensson O, Thorsteinsson L, Palsdottir A, Gudmundsson
G, Amason A, Blöndal H, AbrahamsonM, GrubbA, Olafsson
l, Lundwall
Å.
An isolate of families with hereditary cystalin
C amyloid angiopathy and cerebral haemorrhage in the south
of Iceland. In Amyloid and Amyloidosis (Isobe T, Araki S,
Uchino F, Kito S, Tsubura E, Eds.) New York: Plenum
Publisbing Corporation, 1988, pp 579-584.
22. Palsdottir A, Jonsdottir S, Abrahamson M, Grubb A,
Jensson O. Three RFLPs at the 3' end of the cystalin C gene,
the disease gene in hereditary cystatiD C amyloid angiopathy
(HCCAA) in Iceland. Nucleic Acids Res 1990; 18: 7471.
23. TOOrsteinsson L, Georgsson G, Asgeirsson B, Bjamadottir
M, Olafsson I, Jensson O, Gudmundsson G. On the role of
monocytes/macrophages in
the
pathogenesis of central nervous
system lesions in hereditary cystalin C amyloid angiopathy. J
Neuro! Sci 1992; 108: 121-128.
Klinisk kemi
i
Norden 2, /993
